Response, Peak and Persistence of Varnimcabtagene Autoleucel (IMN-003A), First-in-India Industry CD19-Directed CAR-T Cell Therapy, with Fractionated Infusions for Patients with Relapsed and/or Refractory B Cell Malignancies: Early Results (IMAGINE Study)

Authors :: Sunil Bhat
Sharat Damodar
Pooja Mallya
Akshatha Nayak
Ravi Joshi
Bharath Ram S
Sudarshan Chougule
Deepak MB
Gopinadh Jakka
Sudeshna Dhar
Anne Roshan Joseph
Arun Kumar MG
Murugan Palanisamy
Jeetendra Kumar
Melina Soares
Pallavi Arasu
Sri Ramulu Elluru
Mohammed Manzoor Akheel
Anil Kamat
Source :: Blood. 140:7478-7479
Publication Year :: 2022
Publisher :: American Society of Hematology, 2022.

Full Text Access

Tools